Capital World Investors’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $30M | Hold |
|
|||||
|
2021
Q3 | $41.4M | Hold |
|
|||||
|
2021
Q2 | $34.1M | Hold |
|
|||||
|
2021
Q1 | $42.5M | Hold |
|
|||||
|
2020
Q4 | $43.1M | Hold |
|
|||||
|
2020
Q3 | $63.9M | Hold |
|
|||||
|
2020
Q2 | $80.1M | Hold |
|
|||||
|
2020
Q1 | $21.8M | Buy |
|
|||||
|
2019
Q4 | $8.15M | Hold |
|
|||||
|
2019
Q3 | $10.3M | Hold |
|
|||||
|
2019
Q2 | $27.3M | Hold |
|
|||||
|
2019
Q1 | $29.2M | Hold |
|
|||||
|
2018
Q4 | $39.1M | Hold |
|
|||||
|
2018
Q3 | $92.1M | Sell |
|
|||||
|
2018
Q2 | $85.3M | Buy |
|
|||||
|
2018
Q1 | $76.3M | Hold |
|
|||||
|
2017
Q4 | $45.4M | Hold |
|
|||||
|
2017
Q3 | $55.6M | Hold |
|
|||||
|
2017
Q2 | $30.5M | Hold |
|
|||||
|
2017
Q1 | $37.4M | Buy |
|
|||||
|
2016
Q4 | $18.1M | Sell |
|
|||||
|
2016
Q3 | $32.4M | Hold |
|
|||||
|
2016
Q2 | $37.5M | Hold |
|
|||||
|
2016
Q1 | $37.4M | Hold |
|
|||||
|
2015
Q4 | $55.5M | Buy |
|
|||||
|
2015
Q3 | $20.5M | Buy |
|
|||||
|
2015
Q2 | $20M | Buy |
|